Madison Scientific Inc. secured $7 million in a seed financing round co-led by WARF Ventures and the Isthmus Project, along ...

Anuncia Medical, Inc. ("Anuncia"), a pioneering company in CSF management and neurocritical care, has received Breakthrough ...

Madison Scientific will use the funding to grow its team and to expand testing and prototype development of its SmartShunt ...

CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients with normal pressure hydrocephalus (NPH). At the 90-day primary endpoint ...

This is her second trip to the hospital run by CURE, an American faith-based organization that specializes in treating children like Manjeri’s son who suffer from hydrocephalus. It’s a ...

Normal pressure hydrocephalus (NPH) is one of the few reversible causes of dementia in older adults and accounts for approximately 6% of all dementias. The cardinal sign of NPH is a hypokinetic ...

Normal pressure hydrocephalus is a condition marked by symptoms such as gait disturbances, cognitive impairment, and urinary incontinence, resulting from disruptions in cerebrospinal fluid ...

The Omaha Walk to End Hydrocephalus is one of 40 walks across the country. The Co-Chairs of the Omaha walk Karin Donner and Hailee Schmit joined KETV in the studio to discuss this year’s walk.

Hydrocephalus refers to the medical condition in which an excessive amount of cerebrospinal fluid accumulates within the cranium. It often results in enlarged cerebral ventricles and increased ...